Literature DB >> 9048711

Usefulness of pallidotomy in advanced Parkinson's disease.

F Johansson1, J Malm, E Nordh, M Hariz.   

Abstract

OBJECTIVE: The combined effect of posteroventral pallidotomy and optimal medical treatment was assessed in 22 patients with levodopa sensitive Parkinson's disease.
METHODS: Timed motor tests, video recordings, and computer assisted optoelectronic movement analysis were used for serial hourly assessments performed preoperatively and four and 12 months after operation. Tests were made while patients were on optimal medical therapy.
RESULTS: There were no serious adverse events of surgery. Two of the 22 patients could not complete all the tests after operation. The proportion of dyskinesia periods decreased in the 20 patients and there was a proportional increase in normal or fairly normal occasions. "Off" periods were not significantly affected. In 12 of 13 patients with limb dyskinesia this symptom was completely abolished in the contralateral limbs. There was also some degree of improvement axially and ipsilaterally. Tremor was moderately improved contralaterally. Bradykinesia remained unchanged. Results at 12 months follow up were similar to those at four months.
CONCLUSION: Pallidotomy produced a pronounced positive effect on dyskinesia and a moderate effect on tremor. Bradykinesia was not affected. Posteroventral pallidotomy may be useful in patients with Parkinson's disease who have severe motor fluctuations and may allow an increase in levodopa dose to alleviate bradykinesia in "off" states.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048711      PMCID: PMC486722          DOI: 10.1136/jnnp.62.2.125

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  36 in total

1.  Treatment of parkinsonism by stereotatic thermolesions in the pallidal region. A clinical evaluation of 81 cases.

Authors:  E Svennilson; A Torvik; R Lowe; L Leksell
Journal:  Acta Psychiatr Scand       Date:  1960       Impact factor: 6.392

2.  AAEM minimonograph #35: Clinical experience with transcranial magnetic stimulation.

Authors:  A A Eisen; W Shtybel
Journal:  Muscle Nerve       Date:  1990-11       Impact factor: 3.217

3.  Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.

Authors:  L V Laitinen; A T Bergenheim; M I Hariz
Journal:  J Neurosurg       Date:  1992-01       Impact factor: 5.115

4.  Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants.

Authors:  O Lindvall; H Widner; S Rehncrona; P Brundin; P Odin; B Gustavii; R Frackowiak; K L Leenders; G Sawle; J C Rothwell
Journal:  Ann Neurol       Date:  1992-02       Impact factor: 10.422

5.  Disability profiles and objective quantitative assessment in Parkinson's disease.

Authors:  B Johnels; P E Ingvarsson; M Thorselius; M Valls; G Steg
Journal:  Acta Neurol Scand       Date:  1989-03       Impact factor: 3.209

6.  Response measures in the acute treatment of migraine.

Authors:  E Skovlund; O Flaten
Journal:  Cephalalgia       Date:  1995-12       Impact factor: 6.292

7.  Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease.

Authors:  N Diederich; C G Goetz; G T Stebbins; H L Klawans; K Nittner; A Koulosakis; P Sanker; V Sturm
Journal:  Neurology       Date:  1992-07       Impact factor: 9.910

8.  Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus.

Authors:  S Blond; D Caparros-Lefebvre; F Parker; R Assaker; H Petit; J D Guieu; J L Christiaens
Journal:  J Neurosurg       Date:  1992-07       Impact factor: 5.115

9.  The place of thalamotomy in the treatment of parkinsonism.

Authors:  J Miles; R M Redfern
Journal:  Br J Neurosurg       Date:  1987       Impact factor: 1.596

10.  Optoelectronic movement analysis in Parkinson's disease: effect of selegiline on the disability in de novo parkinsonian patients--a pilot study.

Authors:  B Johnels; P E Ingvarsson; M Matousek; G Steg; E H Heinonen
Journal:  Acta Neurol Scand Suppl       Date:  1991
View more
  9 in total

1.  Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease.

Authors:  F Durif; J J Lemaire; B Debilly; G Dordain
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease.

Authors:  R J McCarter; N H Walton; A F Rowan; S S Gill; M Palomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

3.  The effect of unilateral posteroventral pallidotomy on the kinematics of the reach to grasp movement.

Authors:  K M Bennett; J D O'Sullivan; R F Peppard; P M McNeill; U Castiello
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

4.  Understanding Parkinson's disease and deep brain stimulation: Role of monkey models.

Authors:  Jerrold L Vitek; Luke A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

5.  Outcome of unilateral pallidotomy in advanced Parkinson's disease: cohort study of 32 patients.

Authors:  R M de Bie; P R Schuurman; D A Bosch; R J de Haan; B Schmand; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

Review 6.  Posteroventral medial pallidotomy in Parkinson's disease.

Authors:  A E Lang; J Duff; J A Saint-Cyr; L Trepanier; R E Gross; W Lombardi; E Montgomery; W Hutchinson; A M Lozano
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

7.  Long term outcome of unilateral pallidotomy: follow up of 15 patients for 3 years.

Authors:  P K Pal; A Samii; A Kishore; M Schulzer; E Mak; S Yardley; I M Turnbull; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

8.  Unilateral pallidotomy for Parkinson's disease: results after more than 1 year.

Authors:  A Schrag; M Samuel; E Caputo; T Scaravilli; M Troyer; C D Marsden; D G Thomas; A J Lees; D J Brooks; N P Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

9.  Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up.

Authors:  K Pietz; P Hagell; P Odin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.